Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2335020
Max Phase: Preclinical
Molecular Formula: C26H18N2O2
Molecular Weight: 390.44
Molecule Type: Small molecule
Associated Items:
ID: ALA2335020
Max Phase: Preclinical
Molecular Formula: C26H18N2O2
Molecular Weight: 390.44
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(c1ccccc1)c1ccc2[nH]c(-c3ccc(Oc4ccccc4)cc3)nc2c1
Standard InChI: InChI=1S/C26H18N2O2/c29-25(18-7-3-1-4-8-18)20-13-16-23-24(17-20)28-26(27-23)19-11-14-22(15-12-19)30-21-9-5-2-6-10-21/h1-17H,(H,27,28)
Standard InChI Key: GWRSBTQVOWIZTP-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 390.44 | Molecular Weight (Monoisotopic): 390.1368 | AlogP: 6.25 | #Rotatable Bonds: 5 |
Polar Surface Area: 54.98 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 11.01 | CX Basic pKa: 4.33 | CX LogP: 6.24 | CX LogD: 6.24 |
Aromatic Rings: 5 | Heavy Atoms: 30 | QED Weighted: 0.36 | Np Likeness Score: -0.82 |
1. Matter H, Zoller G, Herling AW, Sanchez-Arias JA, Philippo C, Namane C, Kohlmann M, Pfenninger A, Voss MD.. (2013) Benzimidazole-carboxamides as potent and bioavailable stearoyl-CoA desaturase (SCD1) inhibitors from ligand-based virtual screening and chemical optimization., 23 (6): [PMID:23395660] [10.1016/j.bmcl.2013.01.030] |
Source(1):